{
    "nctId": "NCT01281137",
    "briefTitle": "Study of Changes in Estrogen Levels and Grip Strength in Postmenopausal Women Who Have Received 4 to 6 Years of Hormone Therapy for Breast Cancer and Are Currently Receiving Letrozole on Clinical Trial IBCSG-35-07",
    "officialTitle": "SOLE Estrogen Substudy (SOLE-EST) - Investigating Changes in Estrogen Levels and Grip Strength for Patients Participating in the SOLE Trial",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 104,
    "primaryOutcomeMeasure": "Levels of Estrone (E1), Estradiol (E2), and Estrone Sulphate (E1S) Among Patients in the Longitudinal Analysis Population",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Previously diagnosed with breast cancer\n\n  * Endocrine-responsive, node-positive, resectable disease\n* Disease-free following 4-6 years of prior adjuvant endocrine therapy with selective estrogen-receptor modulators and/or aromatase inhibitors\n* Patient must be currently enrolled on clinical trial IBCSG-35-07 as well as the Quality-of-Life substudy\n* Hormone receptor status not specified\n\nPATIENT CHARACTERISTICS:\n\n* Postmenopausal\n\nPRIOR CONCURRENT THERAPY:\n\n* See Disease Characteristics",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}